相关临床试验
84
7 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1865
进行中（未招募）
3
3.6%
已完成
47
56.0%
Enrolling By Invitation
1
1.2%
尚未招募
3
3.6%
招募中
12
14.3%
终止
7
8.3%
Unknown
1
1.2%
撤回
10
11.9%
暂无批准数据
- Ultrasound AI received FDA De Novo clearance for its Delivery Date AI technology, a cloud-based system that predicts delivery dates using standard ultrasound images. - The AI system demonstrated remarkable accuracy with a 0.92 R² value in predicting days to delivery in a study of over 5,700 patients published in The Journal of Maternal-Fetal & Neonatal Medicine. - The technology is designed to aid clinical decision-making in pregnancies where traditional dating methods are unreliable and aims to reduce the burden of preterm birth. - The system is compatible with most existing ultrasound machines and can be installed in minutes with minimal workflow disruption.
- University of Kentucky researchers are conducting the LiBBY Study to assess medical cannabis for managing agitation and discomfort in late-stage dementia patients. - The study, funded by the NIH and approved by the FDA, seeks alternatives to sedatives, aiming to improve patient comfort and engagement during their final years. - Researchers emphasize the need for evidence-based treatments in palliative care, offering a monitored alternative to unsupervised self-medication with cannabis. - The LiBBY Study's findings could potentially lead to the inclusion of dementia as a condition eligible for medical marijuana prescriptions in Kentucky.
